Literature DB >> 24355686

Sex differences in first-episode psychosis and in people at ultra-high risk.

Angelo Cocchi1, Antonio Lora2, Anna Meneghelli3, Emanuela La Greca2, Alessia Pisano3, Maria Teresa Cascio3, Antonio Preti4.   

Abstract

Sex-related differences in the clinical expression and outcome of schizophrenia have long been recognized; this study set out to evaluate whether they extend to those subjects who are at high risk of developing psychosis. In a sample enrolled in two early intervention programs in northern Italy, patients with first-episode psychosis (FEP; n=152) were compared to patients at ultra-high risk of psychosis (UHR; n=106) on a series of sex-related clinical characteristics of schizophrenia. In both the FEP and the UHR samples, males outnumbered females. In FEP patients, women had been referred at an older age than men and had a shorter duration of untreated illness (DUI) and of untreated psychosis. In UHR patients no sex differences were found in age of onset or DUI. There was no diagnosis by sex interaction on symptoms severity or level of functioning at presentation. The limited number of women in both samples, and the exclusion of people who were older than 30 and of those with substance dependence may have reduced the extent of sex-related differences in this study. Sex differences of precipitating factors for psychosis might be worthy of further investigation.
© 2013 Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Early intervention in psychosis; Obstetric complications; Risk factors; Schizophrenia; Sex differences

Mesh:

Year:  2013        PMID: 24355686     DOI: 10.1016/j.psychres.2013.11.023

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  Sex and gender differences in symptoms of early psychosis: a systematic review and meta-analysis.

Authors:  Brooke Carter; Jared Wootten; Suzanne Archie; Amanda L Terry; Kelly K Anderson
Journal:  Arch Womens Ment Health       Date:  2022-06-24       Impact factor: 4.405

Review 2.  Gender differences in individuals at high-risk of psychosis: a comprehensive literature review.

Authors:  Ana Barajas; Susana Ochoa; Jordi E Obiols; Lluís Lalucat-Jo
Journal:  ScientificWorldJournal       Date:  2015-01-01

3.  Sensing the Worst: Neurophenomenological Perspectives on Neutral Stimuli Misperception in Schizophrenia Spectrum.

Authors:  Mariateresa Sestito; Josef Parnas; Carlo Maggini; Vittorio Gallese
Journal:  Front Hum Neurosci       Date:  2017-06-02       Impact factor: 3.169

4.  Effects of age and sex on clinical high-risk for psychosis in the community.

Authors:  Frauke Schultze-Lutter; Benno G Schimmelmann; Rahel Flückiger; Chantal Michel
Journal:  World J Psychiatry       Date:  2020-05-19

5.  Structure and stability of symptoms in first episode psychosis: a longitudinal network approach.

Authors:  Max Birchwood; Rachel Upthegrove; Siân Lowri Griffiths; Samuel P Leighton; Pavan Kumar Mallikarjun; Georgina Blake; Linda Everard; Peter B Jones; David Fowler; Joanne Hodgekins; Tim Amos; Nick Freemantle; Vimal Sharma; Max Marshall; Paul McCrone; Swaran P Singh
Journal:  Transl Psychiatry       Date:  2021-11-06       Impact factor: 6.222

6.  Sex Differences in Obesity and Cognitive Function in Chinese Elderly Patients With Chronic Schizophrenia.

Authors:  Wei Li; Sun Lin; Ling Yue; Yuan Fang; Shifu Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-01       Impact factor: 6.055

7.  Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience.

Authors:  Sanne de Wit; Lara M Wierenga; Bob Oranje; Tim B Ziermans; Patricia F Schothorst; Herman van Engeland; René S Kahn; Sarah Durston
Journal:  Neuroimage Clin       Date:  2016-08-13       Impact factor: 4.881

8.  Time-course of clinical symptoms in young people at ultra-high risk for transition to psychosis.

Authors:  Anna Meneghelli; Angelo Cocchi; Maria Meliante; Simona Barbera; Lara Malvini; Emiliano Monzani; Antonio Preti; Mauro Percudani
Journal:  Early Interv Psychiatry       Date:  2021-07-22       Impact factor: 2.721

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.